Lauren Santye, Assistant Editor

The TZA test is faster, more cost-effective, and less labor-intensive than the current test for finding dormant HIV cells.

Initiating biologics before triple therapy increases costs and provides minimal incremental benefit.

Switching from DMARDs to first-line biologics may not be the optimal treatment for RA.

GatherMS aims to fill the resource knowledge gap in the MS landscape.

Women accounted for most of the hospitalization and in-hospital deaths.

Top news of the day from across the health care landscape.

RA patients can consume up to 14 alcoholic beverages per week without increasing the risk of liver damage, but rates increase with increasing levels of alcohol consumption.

Gilead plans to file for approval of novel HIV drug in the United States and Europe this year.

Patient with MS was previously treated for 3 years with natalizumab, a known trigger of progressive multifocal leukoencephalopathy.

Continuous low-dose cisplatin through an implantable device could be a therapeutic option in for patients with ovarian cancer.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses trends in specialty drug cost management.

Top news of the day from across the health care landscape.

As chemotherapy resistance builds, cancer cells develop a new Achilles’ heel.

HIV-positive individuals are twice as likely to die of smoking than the disease.

Biosimilar programs seeks to increase accessibility to expensive medications.

One of 5 patients are non-adherent to antihypertensive medications, a new study finds.

Scientists found that some breast cancer patients have a co-occurrence of genetic mutations.

Top news of the day from across the health care landscape.

The IL-17 inhibitor reduced the number of tender and swollen joints in at least 20% of patients with PsA.

Scientists redesigned a portion of rituximab into a new molecule to treat amyotrophic lateral sclerosis.

A compound in aged cheese, mushrooms, and whole grains found to increase life span by 25% in animal models.

Top news of the day from across the health care landscape.

Probiotic Bifidobacterium longum increases overall quality of life in patients with IBS.

GLUT1 inhibitors could be a potential therapeutic target for the squamous subtype of cancer.

Society for Integrative Oncology releases updated clinical guidelines on integrative breast cancer treatments.

Leader and follower cells depend on each other for survival and invasion.

Top news of the day from across the health care landscape.

Sheila Arquette, RPh, discusses optimal patient support programs in specialty pharmacy.

The creation of novel investigational drugs that target a protein receptor found in fat tissue could pave the way for better treatments for type 2 diabetes.

A cancer diagnosis can cause up to a 3.5% reduction in earnings for men and up to 6% for women.